| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 02/25/2009 | CN101371822A Stomach detention sustained and controlled release medicament releasing system and preparation method |
| 02/25/2009 | CN100463918C Novel epidermal growth factor protein and gene, and methods of use therefor |
| 02/25/2009 | CN100463666C Composition for external use on skin |
| 02/25/2009 | CN100463616C Formula of mung Chinese medicinal composite beverage and production thereof |
| 02/24/2009 | US7495127 Calcium-activated potassium channel (BK channel) with opening activity equivalent to or higher than that of maxikdiol, and has high specificity; pimaric acid, dihydropimaric acid, dihydroisopimarinol, sandaracopimaric acid, isopimaric acid, and dihydroisopimaric acid |
| 02/24/2009 | US7495114 Cytotoxic agents containing novel potent taxanes and their therapeutic use |
| 02/24/2009 | US7495110 Benzimidazole derivatives and their use as GnRH antagonists |
| 02/24/2009 | US7495109 Nociceptin analogs |
| 02/24/2009 | US7495104 Quinoline or quinazoline derivatives inhibiting auto-phosphorylation of fibroblast growth factor receptors |
| 02/24/2009 | US7495099 Polyethylene glycol-polyglutamic acid block copolymer conjugates with e.g. 7-ethyl-10-hydroxycamptothecin or topotecan for sustained release; water solubility, anticancer agents |
| 02/24/2009 | US7495020 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders |
| 02/24/2009 | US7495004 Purine derivatives as liver X receptor agonists |
| 02/24/2009 | US7494997 excellent BCR-ABL tyrosine kinase inhibitory activity; to treat leukemias; 3-bromo-4-(4-methylpiperazin-1-ylmethyl)-N-{4-methyl-3-[4-(3-pyridyl)pyrimidin-2-ylamino]phenyl}benzamide; compounds with cell growth inhibitory effect |
| 02/24/2009 | US7494989 Pyridine compounds useful as N-type calcium channel antagonists |
| 02/24/2009 | US7494978 Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
| 02/24/2009 | US7494972 Administering a polypeptide comprising a V-type immunoglobulin domain followed by two C-type domains of soluble human receptor for advanced glycation endproduct (sRAGE) by injection, liposome, mouth, eye, nose or topically |
| 02/24/2009 | US7494644 contacting a myocardial cells with genetic engineered mammalian cells modified to express a connexin 43 proteins, to establishing electrical coupling between cardiomyocytes and recombinant cells; treatment of cardiac disease or tissue repair |
| 02/24/2009 | CA2469813C Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5 |
| 02/24/2009 | CA2432085C Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands |
| 02/24/2009 | CA2426221C New neurokinin antagonists, processes for preparing them and pharmaceutical compositions containing these compounds |
| 02/24/2009 | CA2316972C Method for inhibiting cyclooxygenase-2 and tumor necrosis factor alpha |
| 02/24/2009 | CA2297406C Tricyclic vasopressin agonists |
| 02/24/2009 | CA2225416C A triazolylmethyl-indole ethylamine bisulfate salt |
| 02/24/2009 | CA2179029C Vertebrate embryonic pattern-inducing hedgehog-like proteins |
| 02/24/2009 | CA2174556C Recombinant p53 adenovirus methods and compositions |
| 02/19/2009 | WO2009023360A2 Bacterial packaging strains useful for generation and production of recombinant double-stranded rna nucleocapsids and uses thereof |
| 02/19/2009 | WO2009023270A2 Compositions and methods for modifying properties of biologically active polypeptides |
| 02/19/2009 | WO2009022731A1 P2x4 receptor antagonist |
| 02/19/2009 | WO2009022730A1 P2x4 receptor antagonist |
| 02/19/2009 | WO2009022722A1 Tricyclic amine compound |
| 02/19/2009 | WO2009022721A1 Tricyclic amide compound |
| 02/19/2009 | WO2009022720A1 Five-membered heterocyclic compound |
| 02/19/2009 | WO2009022687A1 Phenylacetic acid compound |
| 02/19/2009 | WO2009022642A1 Novel salt of isoquinoline compound and crystal thereof |
| 02/19/2009 | WO2009022633A1 Bicyclic acylguanidine derivative |
| 02/19/2009 | WO2009022096A1 Drug combinations for the treatment of sialorrhoea |
| 02/19/2009 | WO2008063842A3 Methods of treating neuropathic pain with agonists of ppar-gamma |
| 02/19/2009 | WO2008057246A3 Method for treating inflammatory disorders |
| 02/19/2009 | US20090048447 Method for decreasing opioid metabolism |
| 02/19/2009 | US20090048435 Oligonucleotide modulation of cell adhesion |
| 02/19/2009 | US20090048350 Gastrointestinal absorption enhancer mediated by proton-coupled transporter and its preparing method |
| 02/19/2009 | US20090048324 Alternate morpheein forms of allosteric proteins as a target for the development of bioactive molecules |
| 02/19/2009 | US20090048307 5-pyridyl-1, 3-azole compounds, process for producing the same and use there of |
| 02/19/2009 | US20090048284 Therapeutic compounds |
| 02/19/2009 | US20090048251 4-(1h-indazol-5-yl-amino)-quinazoline compounds as erbb receptor tyrosine kinase inhibitors for the treatment of cancer |
| 02/19/2009 | US20090048236 New phenylalanine derivatives |
| 02/19/2009 | US20090048226 Inhibitors of caspases |
| 02/19/2009 | US20090048201 Use of targeted cross-linked nanoparticles for in vivo gene delivery |
| 02/19/2009 | US20090048198 Compositions and methods for nucleic acid delivery systems |
| 02/19/2009 | US20090048197 Lipid Nanoparticle Based Compositions and Methods for the Delivery of Biologically Active Molecules |
| 02/19/2009 | US20090048168 Inhibitors of bcl-2 |
| 02/19/2009 | US20090048165 Anti-hiv agent |
| 02/19/2009 | US20090048163 Nucleic acid and protein sequences of asporins |
| 02/19/2009 | US20090047741 Compositions and methods comprising a ligand of chemerin R |
| 02/19/2009 | US20090047687 Indane Acetic Acid Derivatives and Their Use as Pharmaceutical Agents, Intermediates, and Method of Preparation |
| 02/19/2009 | US20090047358 Phospholipid-based powders for drug delivery |
| 02/19/2009 | US20090047348 Poly(organophosphazene) hydrogels for drug delivery, preparation method thereof and use thereof |
| 02/19/2009 | US20090047342 Methods of Treating Infectious Diseases |
| 02/19/2009 | US20090047300 Blood-brain barrier epitopes and uses thereof |
| 02/19/2009 | US20090047277 Recombinant il-9 antibodies and uses thereof |
| 02/19/2009 | US20090047271 Stable recombinant adenosine deaminase |
| 02/19/2009 | US20090047265 Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof |
| 02/19/2009 | US20090047264 Antiallergic agent, utilization thereof for reducing allergy and method of reducing allergy |
| 02/19/2009 | US20090047263 Nuclear reprogramming factor and induced pluripotent stem cells |
| 02/19/2009 | US20090047255 Alphavirus and Alphavirus Replicon Particle Formulations and Methods |
| 02/19/2009 | CA2695984A1 Tricyclic amine compound |
| 02/19/2009 | CA2695977A1 Tricyclic amide compound |
| 02/19/2009 | CA2695878A1 5-membered heterocyclic compound |
| 02/19/2009 | CA2695757A1 Phenylacetic acid compound |
| 02/19/2009 | CA2695636A1 Bicyclic acylguanidine derivative |
| 02/18/2009 | EP2025752A2 Antisense oligonucleotides for the inhibition of expression of type I procollagen |
| 02/18/2009 | EP2025680A1 Degranulation inhibitor |
| 02/18/2009 | EP2025676A1 Novel indazole derivative having spiro ring structure in side chain |
| 02/18/2009 | EP2025671A1 Nitrogen-containing heterocyclic compound and thrombopoietin receptor activator |
| 02/18/2009 | EP2025666A2 Thiolalkyl benzoic acid derivatives |
| 02/18/2009 | EP2025347A1 Prophylactic and therapeutic agent for cancer |
| 02/18/2009 | EP2023911A2 Compounds a-r-x for the manufacture of pharmaceutical preparations |
| 02/18/2009 | EP1679372B1 Novel plexin polypeptide, dna encoding the same and use thereof |
| 02/18/2009 | EP1641775B1 2-pyridine alkyne derivatives useful for treating pain |
| 02/18/2009 | EP1614684B1 Diamine derivative, production process, and antioxidizing drug |
| 02/18/2009 | EP1539727B1 Compounds, compositions, and methods for treating cellular proliferative diseases |
| 02/18/2009 | EP1513493B1 Analgesics |
| 02/18/2009 | EP1497265B1 Compounds having affinity at 5ht2c receptor and use thereof in therapy |
| 02/18/2009 | EP1458757B1 Process for the purification and/or isolation of biologically active granulocyte colony stimulating factor |
| 02/18/2009 | EP1444210B1 Qunazoline derivatives as antitumor agents |
| 02/18/2009 | EP1399431B1 Novel nitriles useful as reversible inhibitors of cysteine proteases |
| 02/18/2009 | EP1392298B1 Fused heterocyclic compounds |
| 02/18/2009 | EP1360178B1 Novel heterocyclic analogs of diphenylethylene compounds |
| 02/18/2009 | EP1208097B1 Substituted oxoazaheterocyclyl compounds |
| 02/18/2009 | EP1084137B1 Peptide inhibitors of hepatitis c virus ns3 protease |
| 02/18/2009 | EP1071955B2 Improved immunodiagnostic assays using reducing agents |
| 02/18/2009 | EP1021167B1 High and low load formulations of igf-i in multivesicular liposomes |
| 02/18/2009 | EP0969866B2 Immunotherapy of b-cell malignancies using anti-cd22 antibodies |
| 02/18/2009 | CN101370773A Cycloalkanecarboxamide derivative and method for producing same |
| 02/18/2009 | CN101367851A Oligosaccharide derivative |
| 02/18/2009 | CN101367761A 6,7- substituted-2,2,4-trimethyl-tetrahydroquinoline-1-carboxylic acid aryl amide, synthesis and uses thereof |
| 02/18/2009 | CN101366949A Method for improving feed efficiency and/or growth rate and/or fat reduction of livestock |
| 02/18/2009 | CN101366914A Medicament for tumour restraint, anti-hunger, detoxication, reinforcing phylactic power and preparation method |
| 02/18/2009 | CN101366714A Acetylene derivatives having mGluR5 antagonistic activity |
| 02/18/2009 | CN101366710A Medicinal composition for haemofiltration or hemodialysis |